{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:54:58Z","timestamp":1777535698466,"version":"3.51.4"},"reference-count":34,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:p>INTRODUCTION: The Global Programme to Eliminate Lymphatic Filariasis was launched with the goal of eliminating this disease via the annual mass drug administration (MDA) of a single dose of antifilarial drugs. Adverse drug reactions following MDA are a major factor of poor treatment adherence in several countries. This study assessed the occurrence of adverse drug reactions (ADRs) following the first round of mass treatment in two communities treated with different dosages of diethylcarbamazine (DEC) in the City of Recife, Brazil. METHODS: Population-based cross-sectional surveys were conducted in a random sample of the population living in both communities (Areas I and II). The dose of DEC recommended by the WHO (6mg\/kg) was calculated based on the individual's weight-for-age. In Area II, weight differences between the genders were also considered when determining dosage. Data were obtained through interviews conducted in the first 12 to 48h and on the 5th day after MDA during household visits. RESULTS: A total of 487 and 365 individuals were interviewed in Areas I and II, respectively. The prevalence of ADRs in Area I (23.6; 95%CI: 19.1-29.5) was higher than in Area II (16.2; 95%CI:11.9-21.5)(p=0.0078). The prevalence of ADRs among females was higher than in males in Area I (p=0.0021). In Area II, no significant difference between the genders was observed (p=0.1840). Age was not associated with ADRs in either area. CONCLUSIONS: Adjusting MDA dosage schedules according to weight-for-age and sex may be may contribute to reduce the occurrence of adverse drug reactions in the population.<\/jats:p>","DOI":"10.1590\/s0037-86822012000600017","type":"journal-article","created":{"date-parts":[[2013,1,5]],"date-time":"2013-01-05T12:48:27Z","timestamp":1357390107000},"page":"745-750","source":"Crossref","is-referenced-by-count":16,"title":["Adverse reactions following mass drug administration with diethylcarbamazine in lymphatic filariasis endemic areas in the Northeast of Brazil"],"prefix":"10.1590","volume":"45","author":[{"given":"Ana Wl\u00e1dia","family":"Lima","sequence":"first","affiliation":[{"name":"Universidade Federal de Pernambuco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zulma","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zailde Carvalho dos","family":"Santos","sequence":"additional","affiliation":[{"name":"Universidade Federal de Pernambuco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gertrudes Monteiro da","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Braga","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1590\/S0037-86822008000200018","article-title":"Workshop para avalia\u00e7\u00e3o da situa\u00e7\u00e3o epidemiol\u00f3gica da filariose linf\u00e1tica no Munic\u00edpio de Bel\u00e9m, Par\u00e1, norte do Brasil","volume":"41","author":"Freitas H","year":"2008","journal-title":"Rev Soc Bras Med Trop","ISSN":"https:\/\/id.crossref.org\/issn\/0037-8682","issn-type":"print"},{"key":"ref2","series-title":"Lymphatic Filariasis elimination","year":"2011"},{"key":"ref3","first-page":"365","article-title":"Global programme to eliminate lymphatic filariasis","volume":"85","year":"2010","journal-title":"Wkly Epidemiol Rec","ISSN":"https:\/\/id.crossref.org\/issn\/0049-8114","issn-type":"print"},{"key":"ref4","first-page":"491","article-title":"Strategies and tools for the control\/elimination of lymphatic filariasis","volume":"75","author":"Ottesen EA","year":"1997","journal-title":"Bull World Health Organ","ISSN":"https:\/\/id.crossref.org\/issn\/0042-9686","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.trstmh.2008.05.023","article-title":"Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance","volume":"102","author":"Babu BV","year":"2008","journal-title":"Trans R Soc Trop Med Hyg","ISSN":"https:\/\/id.crossref.org\/issn\/0035-9203","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.inhe.2010.12.001","article-title":"Coverage and compliance to mass drug administration for lymphatic filariasis elimination in a district of Kerala, India","volume":"3","author":"Nujum ZT","year":"2011","journal-title":"International Health"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-3156.2009.02443.x","article-title":"Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State, India 2008","volume":"15","author":"Cantey PT","year":"2010","journal-title":"Trop Med Int Health","ISSN":"https:\/\/id.crossref.org\/issn\/1360-2276","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1017\/S0031182000007423","article-title":"An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis","volume":"121","author":"Horton J","year":"2000","journal-title":"Parasitology","ISSN":"https:\/\/id.crossref.org\/issn\/0031-1820","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/clinids\/7.3.341","article-title":"Efficacy of diethylcarbamazine in eradicating infection with lymphatic-dwelling filariae in humans","volume":"7","author":"Ottesen EA","year":"1985","journal-title":"Rev Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0162-0886","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1590\/S0037-86821997000300010","article-title":"Diethylcarbamazine in the treatment of Bancroft's filariasis","volume":"30","author":"Dreyer G","year":"1997","journal-title":"Rev Soc Bras Med Trop","ISSN":"https:\/\/id.crossref.org\/issn\/0037-8682","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-3156.2004.01247.x","article-title":"Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India","volume":"9","author":"Babu BV","year":"2004","journal-title":"Trop Med Int Health","ISSN":"https:\/\/id.crossref.org\/issn\/1360-2276","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1046\/j.1360-2276.2003.01146.x","article-title":"Treatment costs and work time loss due to episodic adenolymphangitis in lymphatic filariasis patients in rural communities of Orissa, India","volume":"8","author":"Babu BV","year":"2003","journal-title":"Trop Med Int Health","ISSN":"https:\/\/id.crossref.org\/issn\/1360-2276","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4269\/ajtmh.2003.68.568","article-title":"Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000","volume":"68","author":"McLaughlin SI","year":"2003","journal-title":"Am J Trop Med Hyg","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.trstmh.2005.07.016","article-title":"Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India","volume":"100","author":"Babu BV","year":"2006","journal-title":"Trans R Soc Trop Med Hyg","ISSN":"https:\/\/id.crossref.org\/issn\/0035-9203","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1365-3156.1999.00427.x","article-title":"Screening of army soldiers for Wuchereria bancrofti infection in the metropolitan Recife region, Brazil: implications for epidemiological surveillance","volume":"4","author":"Medeiros Z","year":"1999","journal-title":"Trop Med Int Health","ISSN":"https:\/\/id.crossref.org\/issn\/1360-2276","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1179\/136485908X311821","article-title":"The epidemiological delimitation of lymphatic filariasis in an endemic area of Brazil, 41 years after the first recorded case","volume":"102","author":"Medeiros Z","year":"2008","journal-title":"Ann Trop Med Parasitol","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4983","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0035-9203(95)90014-4","article-title":"Bancroftian filariasis in two urban areas of Recife, Brazil: pre-control observations on infection and disease","volume":"89","author":"Albuquerque MF","year":"1995","journal-title":"Trans R Soc Trop Med Hyg","ISSN":"https:\/\/id.crossref.org\/issn\/0035-9203","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1590\/S0037-86822008000100006","article-title":"Aspects of the social realities of children and adolescents seen at a reference service for bancroftian filariasis in Recife, state of Pernambuco","volume":"41","author":"Mattos D","year":"2008","journal-title":"Rev Soc Bras Med Trop","ISSN":"https:\/\/id.crossref.org\/issn\/0037-8682","issn-type":"print"},{"key":"ref19","first-page":"437","article-title":"Global programme to eliminate lymphatic filariasis: progress report on mass drug administration in 2008","volume":"42","year":"2009","journal-title":"Weekly epidemiological record","ISSN":"https:\/\/id.crossref.org\/issn\/0049-8114","issn-type":"print"},{"key":"ref20","series-title":"Caracter\u00edsticas da popula\u00e7\u00e3o e domic\u00edlios, resultados do universo da popula\u00e7\u00e3o","year":"2000"},{"key":"ref21","series-title":"Lymphatic filariasis","year":"2011"},{"key":"ref22","first-page":"1","author":"Kuczmarski RJ","year":"2000"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMoa021309","article-title":"Mass treatment to eliminate filariasis in Papua New Guinea","volume":"347","author":"Bockarie MJ","year":"2002","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4269\/ajtmh.2007.77.1069","article-title":"The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt","volume":"77","author":"El-Setouhy M","year":"2007","journal-title":"Am J Trop Med Hyg","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1365-3156.2008.02120.x","article-title":"Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka","volume":"13","author":"Gunawardena S","year":"2008","journal-title":"Trop Med Int Health","ISSN":"https:\/\/id.crossref.org\/issn\/1360-2276","issn-type":"print"},{"key":"ref26","first-page":"315","article-title":"Report on active surveillance for adverse events following the use of drug co-administrations in the global programme to eliminate lymphatic filariasis","volume":"78","year":"2003","journal-title":"Wkly Epidemiol Rec","ISSN":"https:\/\/id.crossref.org\/issn\/0049-8114","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0035-9203(94)90311-5","article-title":"Tolerance of diethylcarbamazine by microfilaraemic and amicrofilaraemic individuals in an endemic area of Bancroftian filariasis, Recife, Brazil","volume":"88","author":"Dreyer G","year":"1994","journal-title":"Trans R Soc Trop Med Hyg","ISSN":"https:\/\/id.crossref.org\/issn\/0035-9203","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0035-9203(95)90561-8","article-title":"Comparative efficacy of three different diethylcarbamazine regimens in lymphatic filariasis","volume":"89","author":"Andrade LD","year":"1995","journal-title":"Trans R Soc Trop Med Hyg","ISSN":"https:\/\/id.crossref.org\/issn\/0035-9203","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-3156.2000.00644.x","article-title":"Tolerability and efficacy of single-dose diethyl carbamazine (DEC) or ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, south India","volume":"5","author":"Subramanyam Reddy G","year":"2000","journal-title":"Trop Med Int Health","ISSN":"https:\/\/id.crossref.org\/issn\/1360-2276","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-3156.2000.00644.x","article-title":"Tolerability and efficacy of single-dose diethyl carbamazine (DEC) or ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, south India","volume":"5","author":"Subramanyam Reddy G","year":"2000","journal-title":"Trop Med Int Health","ISSN":"https:\/\/id.crossref.org\/issn\/1360-2276","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1365-2125.1998.00817.x","article-title":"Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies","volume":"46","author":"Martin RM","year":"1998","journal-title":"Br J Clin Pharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0306-5251","issn-type":"print"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2125.2010.03811.x","article-title":"Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands","volume":"71","author":"Rodenburg EM","year":"2010","journal-title":"British J Clin Pharmacol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1590\/S0037-86822005000300003","article-title":"Bancroftian filariasis in an endemic area of Brazil: differences between genders during puberty","volume":"38","author":"Braga C","year":"2005","journal-title":"Rev Soc Bras Med Trop","ISSN":"https:\/\/id.crossref.org\/issn\/0037-8682","issn-type":"print"},{"key":"ref34","first-page":"12","article-title":"Tolerability and efficacy of a three-age class dosage schedule of diethylcarbamazine citrate (DEC) in the treatment of microfilaria carriers of Wuchereria bancrofti and its implications in mass drug administration (MDA) strategy for elimination of lymphatic filariasis (LF)","volume":"37","author":"Pani SP","year":"2005","journal-title":"J Commun Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5138","issn-type":"print"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rsbmt\/v45n6\/17.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:33:17Z","timestamp":1562545997000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822012000600017&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0037-86822012000600017"],"URL":"https:\/\/doi.org\/10.1590\/s0037-86822012000600017","relation":{},"ISSN":["0037-8682"],"issn-type":[{"value":"0037-8682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}